Growth Metrics

Quest Diagnostics (DGX) Receivables - Net: 2009-2025

Historic Receivables - Net for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $1.5 billion.

  • Quest Diagnostics' Receivables - Net rose 5.81% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 5.81%. This contributed to the annual value of $1.3 billion for FY2024, which is 7.77% up from last year.
  • According to the latest figures from Q3 2025, Quest Diagnostics' Receivables - Net is $1.5 billion, which was up 2.61% from $1.4 billion recorded in Q2 2025.
  • Over the past 5 years, Quest Diagnostics' Receivables - Net peaked at $1.5 billion during Q3 2021, and registered a low of $1.2 billion during Q4 2022.
  • Over the past 3 years, Quest Diagnostics' median Receivables - Net value was $1.3 billion (recorded in 2024), while the average stood at $1.3 billion.
  • Its Receivables - Net has fluctuated over the past 5 years, first surged by 42.18% in 2021, then decreased by 16.90% in 2022.
  • Over the past 5 years, Quest Diagnostics' Receivables - Net (Quarterly) stood at $1.4 billion in 2021, then declined by 16.90% to $1.2 billion in 2022, then grew by 1.26% to $1.2 billion in 2023, then increased by 7.77% to $1.3 billion in 2024, then increased by 5.81% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.4 billion during Q1 2025.